Stay updated on DUR-928 Alcoholic Hepatitis Clinical Trial
Sign up to get notified when there's something new on the DUR-928 Alcoholic Hepatitis Clinical Trial page.

Latest updates to the DUR-928 Alcoholic Hepatitis Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision/version tag was updated from **v3.5.0** to **v3.5.3**, indicating a minor technical site release without altering the clinical trial content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 across the page. No changes to the study details, eligibility criteria, or outcome measures.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing content or study details were modified.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no study content or critical information appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded NEJM Evid. publication citation for Larsucosterol in Alcoholic Hepatitis and updated to revision v3.4.1; removed the Erratum entry for that article in Publications.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page adds glossary toggle controls (Show glossary / Hide glossary) and updates release notes to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Old labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to DUR-928 Alcoholic Hepatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DUR-928 Alcoholic Hepatitis Clinical Trial page.